3
Announcements
Trials
Browse
Landscape
Status
Terminated
2
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Pancreatitis, Chronic
1
Pancreatic carcinoma, familial
1
Pancreatic Neoplasms
1
Hereditary pancreatitis
1
Disease
1
Diabetes Mellitus
1
Interventions
Oxaliplatin
197
Bevacizumab
161
Fluorouracil
154
Capecitabine
137
Gemcitabine
134
Leucovorin
111
pembrolizumab
99
Cisplatin
94
Drug Therapy
89
Irinotecan
80
Radiotherapy
73
sintilimab
70
130-nm albumin-bound paclitaxel
66
durvalumab
65
Paclitaxel
64
Specimen Handling
62
Cetuximab
61
lenvatinib
59
tislelizumab
58
Nivolumab
55
Magnetic Resonance Spectroscopy
55
Folfox protocol
55
Blood Specimen Collection
52
atezolizumab
47
Biopsy
46
Surgical Procedures, Operative
40
Taxes
39
Albumin-Bound Paclitaxel
39
Immune Checkpoint Inhibitors
37
HMPL-013
36
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Clinical Laboratory Techniques
×
Gastrointestinal
×
Clear all
NCT04743479
2023-09-01
ESPRIT-AI
Changhai Hospital
Recruiting
5,000 enrolled